Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

This month in security with Tony Anscombe – September 2025 edition The past 30 days have seen no shortage of new threats and incidents that brought into sharp relief the need for well-thought-out ...